Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jan 13, 2021
Open Peer Review Period: Jan 12, 2021 - Mar 9, 2021
Date Accepted: Sep 7, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Stakeholders’ Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study

Sekandi J, Buregyeya E, Onuoha NA, Zalwango S, Kasiita V, Nakkonde D, Turinawe J, Kakaire R, Davis-Olwell P, Atuyambe L

Stakeholders’ Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study

JMIR Mhealth Uhealth 2021;9(10):e27131

DOI: 10.2196/27131

PMID: 34704961

PMCID: 8581755

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Title: Stakeholders’ Attitudes, Perceived Barriers, and Benefits of Using Video Observed Treatment for Monitoring Tuberculosis Patients in Uganda: A Qualitative Study

  • Juliet Sekandi; 
  • Esther Buregyeya; 
  • Nicole Amara Onuoha; 
  • Sarah Zalwango; 
  • Vincent Kasiita; 
  • Damalie Nakkonde; 
  • Julius Turinawe; 
  • Robert Kakaire; 
  • Paula Davis-Olwell; 
  • Lynn Atuyambe

ABSTRACT

Background:

Directly Observed Therapy (DOT) is the recommended standard for monitoring adherence to tuberculosis (TB) treatment worldwide, but it is challenging to implement in resource-limited settings. DOT is labor-intensive and often burdensome for both patients and healthcare workers. Video directly observed therapy (VDOT) is a novel patient-centered alternative that uses mobile technology to ‘observe’ patients taking medication remotely. However, the attitudes, perceptions, and acceptability of end-users have not been evaluated in Africa.

Objective:

The study aimed to evaluate the stakeholders’ attitudes and perceived barriers and benefits of using VDOT for monitoring TB patients in urban Uganda.

Methods:

A qualitative cross-sectional study was conducted in Kampala, Uganda, from April to May 2018. We conducted five focus group discussions, each composed of six participants. Stakeholder groups included male and female TB patients (n=2 groups), health providers (n=1), caregivers (n=1), and community DOT volunteer workers (n=1). Guided by the Technology Acceptance Model (TAM), we explored several dimensions including perceived usefulness, perceived ease of use, intent to use, and the external variables that affect the adoption of VDOT. Eligible participants were 18 years or older who provided written informed consent. We included only TB patients who had been on treatment for at least two months to ensure that they were no longer infectious. A convenience sample of patients was recruited at one of the TB clinics in Kampala to constitute two focus groups stratified by sex. Health provider and community volunteer groups were composed of available health workers. Trained interviewers conducted unstructured interviews, which were audio-recorded, transcribed, and analyzed into emerging themes using content analysis.

Results:

VDOT was acceptable across all categories of stakeholders interviewed. Health providers and community DOT workers perceived the potential usefulness and ease of use. In contrast, patients perceived the benefits of saving time and money because of the minimal need to travel to clinics for in-person monitVDOT was acceptable across all categories of stakeholders interviewed. Health providers and community DOT workers perceived the potential usefulness and ease of use. In contrast, patients perceived the benefits of saving time and money because of the minimal need to travel to clinics for in-person monitoring. Emergent themes included privacy concerns about unintended disclosure of TB disease status and the lack of skills required to use the VDOT technology. The respondents identified external variables, such as limited access to the internet and electricity. The majority of participants perceived the costs of acquiring a smartphone and paying for internet access as significant barriers to the use of VDOT. Female patients expressed concerns about how recording videos using the VDOT app might interfere with their domestic work time, thereby becoming an inconvenience.oring. Emergent themes included privacy concerns about unintended disclosure of TB disease status and the lack of skills required to use the VDOT technology. The respondents identified external variables, such as limited access to the internet and electricity. The majority of participants perceived the costs of acquiring a smartphone and paying for internet access as significant barriers to the use of VDOT. Female patients expressed concerns about how recording videos using the VDOT app might interfere with their domestic work time, thereby becoming an inconvenience

Conclusions:

VDOT was universally perceived as acceptable and beneficial to the main TB stakeholders in the urban study setting. However, we identified perceived privacy concerns, limited technology skills, and costs related to using VDOT. We recommend careful consideration of the potential barriers when adopting mHealth tools for monitoring treatment adherence in this local African context.


 Citation

Please cite as:

Sekandi J, Buregyeya E, Onuoha NA, Zalwango S, Kasiita V, Nakkonde D, Turinawe J, Kakaire R, Davis-Olwell P, Atuyambe L

Stakeholders’ Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study

JMIR Mhealth Uhealth 2021;9(10):e27131

DOI: 10.2196/27131

PMID: 34704961

PMCID: 8581755

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.